# INSIGHTFUL-FFR Clinical Trial

Study · id `cardio:ct-nct05437900` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05437900](<https://clinicaltrials.gov/study/NCT05437900>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05437900

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2500 participants.

## Technical summary

Registry record NCT05437900. Randomized; no masking; primary purpose treatment. Start 2022-09-22 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2500 participants (planned count; ClinicalTrials.gov record NCT05437900, source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)
- Started: 2022-09-22 (actual) (ClinicalTrials.gov record NCT05437900, source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)
- Primary completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT05437900, source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)
- Completion: 2030-06-30 (anticipated) (ClinicalTrials.gov record NCT05437900, source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)
- Countries: Belgium; China; France; Germany; Italy; Netherlands; Poland; Spain (ClinicalTrials.gov record NCT05437900, source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05437900-2026-01-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: INSIGHTFUL-FFR Clinical Trial
- Condition: Coronary Artery Disease
- Condition: Acute Coronary Syndrome
- Intervention (Procedure): Pressure Microcatheter guided strategy - PIOS MC
- Intervention (Procedure): Pressure Wire guided strategy - PIOS - PW
- Intervention (Procedure): Pressure Microcatheter guided strategy - Standard of care
- Intervention (Procedure): Pressure Wire guided strategy - Standard of care
- Lead sponsor: CoreAalst BV
- Lead sponsor class: INDUSTRY
- Collaborator: Insight Lifetech Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: d24edc306506f5fd8bb0c320562a90994ef7b6ce488fe3d1813487192cbacca1
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
